Skip to Main Content

Paper Details

Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy.
Proc Natl Acad Sci U S A
3
2023
CD8, CD8 T, CD8 T cell, CD8 T cells, ICB, MHC class I, MHC-I, PIKfyve, cancer, cancer cells, major histocompatibility complex class I, mouse, patients, syngeneic mouse models, tumor
Author NameAffiliation
Xuhong CaoMichigan Center for Translational Pathology, University of Michigan ann arbor
Xuhong CaoUniversity of Michigan ann arbor
Marcin CieslikMichigan Center for Translational Pathology, University of Michigan ann arbor
Marcin CieslikUniversity of Michigan ann arbor
Marcin CieslikUniversity of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanRogel Cancer Center, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanRogel Cancer Center, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
  • 1 - 15

Datasets

Release 1.2